Example: dental hygienist
Direct Oral Anticoagulants (DOACs) Guide
3 Direct Oral Anticoagulants (DOACs) Guide S414386A 281375 0517 ©2017 ALLINA HEALTH SYSTEM. TM A TRADEMARK OF ALLINA HEALTH SYSTEM. MINNEAPOLIS HEART INSTITUTE® AND MHI ® ARE TRADEMARKS OF MINNEAPOLIS HEART INSTITUTE, INC. Thrombophilia and Anticoagulation Clinic, Minneapolis Heart Institute®, Abbott Northwestern …
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Switching To and From Various Anticoagulants - …
www.mplsheart.com26 From To Conversion Recommendation Heparinoids/SC Agents, continued LMWH/ subcutaneous (Enoxaparin, Dalteparin, Fondaparinux) heparin …
Major Recommendations for Statin Therapy for ...
www.mplsheart.comGuidance for High-Intensity and Moderate Intensity Statin Dosing High-Intensity Statins • Atorvastatin 40-80 mg • Rosuvastatin 20-40 mg Moderate-Intensity Statins
Switching To and From Various Anticoagulants
www.mplsheart.comStop rivaroxaban Begin agent at time when next dose of rivaroxaban is due warfarin Stop rivaroxaban Start warfarin and consider starting bridging agent at next rivaroxaban due time Start INR monitoring 2 days after stopping rivaroxaban (INR values drawn sooner may be falsely elevated by rivaroxaban) Stop bridging agent once goal INR is achieved
Related documents
Efficacy and safety of early parenteral anticoagulation as ...
excellence.acforum.orgDec 04, 2014 · © Schattauer 2014 Thrombosis and Haemostasis 112.6/2014 Blood Coagulation, Fibrinolysis and Cellular Haemostasis 1120 Efficacy and safety of early parenteral ...